Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest

被引:24
|
作者
Wiegratz, Inka
Mittmann, Katrin
Dietrich, Horst
Zimmermann, Thomas
Kuhl, Herbert
机构
[1] Goethe Univ Frankfurt, Dept Obstet & Gynecol, D-60590 Frankfurt, Germany
[2] Jenapharm GmbH & Co KG, Jena, Germany
关键词
oral contraceptives; ethinyl estradiol; dienogest; fertility regain; conception rate;
D O I
10.1016/j.fertnstert.2005.11.052
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the conception rate after cessation of a combination of 30 mu g ethinyl E-2 and 2 mg dienogest (EE/DNG). Design: Prospective observational study. Setting: Population-based cohort in Germany. Patient(s): Women who wished to become pregnant after cessation of an oral contraceptive (EE/DNG). Intervention(s): None. Main Outcome Measure(s): Cumulative conception rate within 1 year after termination of EE/DNG and time to pregnancy. Result(s): After 1 year follow-up, the cumulative pregnancy rate was 86.6% (full analysis set; n = 706). When all participants with complete data were analyzed (n = 652), the cumulative pregnancy rate was 94.0%. More than 15% of the patients conceived in each of the first three cycles after termination of EE/DNG; the mean time to pregnancy was 3.5 cycles. The preceeding duration of treatment with EE/DNG did not influence the conception rate. Except in the youngest age group (16-18 years), a certain delay was observed in the other age groups. Conclusion(s): The present prospective study revealed only a slight delay in regaining fertility during the first three cycles after cessation of EE/DNG. Thereafter, the cumulative rate of conception did not differ form that observed in fertile women who attempted to become pregnant without prior conception.
引用
收藏
页码:1812 / 1819
页数:8
相关论文
共 50 条
  • [31] Effects of two oral contraceptives, containing 30 or 20 μg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women
    Ferreira, ACP
    Montes, MBA
    Franceschini, SA
    Toloi, MRT
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2001, 46 (05): : 265 - 270
  • [32] Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)
    Archer, DF
    Maheux, R
    DelConte, A
    O'Brien, FB
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) : S39 - S44
  • [33] The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study
    Bifulco, Giuseppe
    Sardo, Attilio Di Spiezio
    De Rosa, Nicoletta
    Greco, Elena
    Spinelli, Marialuigia
    Di Carlo, Costantino
    Tommaselli, Giovanni A.
    Nappi, Carmine
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (12) : 949 - 955
  • [34] A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids, and carbohydrate metabolism
    Endrikat, J
    Klipping, C
    Gerlinger, C
    Ruebig, A
    Schmidt, W
    Holler, T
    Düsterberg, B
    CONTRACEPTION, 2001, 64 (04) : 235 - 241
  • [35] The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir
    Garg, Varun
    van Heeswijk, Rolf
    Yang, Yijun
    Kauffman, Robert
    Smith, Frances
    Adda, Nathalie
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10) : 1574 - 1583
  • [36] Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol
    Boyd, RA
    Zegarac, EA
    Posvar, EL
    Flack, MR
    CONTRACEPTION, 2001, 63 (02) : 71 - 76
  • [37] Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol
    Jick, SS
    Kaye, JA
    Russmann, S
    Jick, H
    CONTRACEPTION, 2006, 73 (03) : 223 - 228
  • [38] Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers
    Xin, X.
    Wu, Y.
    Liu, X.
    Sun, C.
    Geng, T.
    Ding, L.
    DRUG RESEARCH, 2016, 66 (02) : 100 - 106
  • [39] Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest
    Fraser, Ian S.
    Jensen, Jeffrey
    Schaefers, Matthias
    Mellinger, Uwe
    Parke, Susanne
    Serrani, Marco
    CONTRACEPTION, 2012, 86 (02) : 96 - 101
  • [40] Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study
    Di Carlo, Costantino
    Gargano, Virginia
    Sparice, Stefania
    Tommaselli, Giovanni A.
    Bifulco, Giuseppe
    Nappi, Carmine
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (12) : 1048 - 1050